TY - JOUR
T1 - Circadian determinations of cortisol, prolactin and melatonin in chronic methyl-phenyl-tetrahydropyridine-treated monkeys
AU - Barcia, Carlos
AU - Bautista, Víctor
AU - Sánchez-Bahillo, Angel
AU - Fernández-Villalba, Emiliano
AU - Navarro-Ruis, Juana María
AU - Fernández Barreiro, Andrés
AU - Poza Y Poza, Máximo
AU - Herrero, María Trinidad
PY - 2003
Y1 - 2003
N2 - The aim of this study was to investigate whether prolac-tin, melatonin and cortisol are altered in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys and if so, whether MPTP may alter the availability of these hormones in chronic experimental parkinson-ism. Furthermore, vegetative and sleep disorders have been described in both parkinsonian patients and in MPTP chronic monkeys; these may result indirectly from concomitant hormonal variations. Seven adult male cynomolgus monkeys were used for this experiment. Five were treated with systemic doses of intravenous MPTP but not withL-DOPA or dopaminergic agonists. In their 3rd year of parkinsonism, plasma samples were obtained day and night at 3-hour intervals. Sample collection was repeated three times for each animal. Prolactin, melatonin and cortisol concentrations were determined by enzyme immunoassay and compared with samples taken from the control group. Both MPTP-treated monkeys and the control group displayed a similar secretion pattern for the three hormones, except at several specific times when prolactin and melatonin showed significant differences. No changes were found for cortisol. The results suggest a possible alteration of hormonal metabolism in chronic MPTP parkinsonian monkeys.
AB - The aim of this study was to investigate whether prolac-tin, melatonin and cortisol are altered in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys and if so, whether MPTP may alter the availability of these hormones in chronic experimental parkinson-ism. Furthermore, vegetative and sleep disorders have been described in both parkinsonian patients and in MPTP chronic monkeys; these may result indirectly from concomitant hormonal variations. Seven adult male cynomolgus monkeys were used for this experiment. Five were treated with systemic doses of intravenous MPTP but not withL-DOPA or dopaminergic agonists. In their 3rd year of parkinsonism, plasma samples were obtained day and night at 3-hour intervals. Sample collection was repeated three times for each animal. Prolactin, melatonin and cortisol concentrations were determined by enzyme immunoassay and compared with samples taken from the control group. Both MPTP-treated monkeys and the control group displayed a similar secretion pattern for the three hormones, except at several specific times when prolactin and melatonin showed significant differences. No changes were found for cortisol. The results suggest a possible alteration of hormonal metabolism in chronic MPTP parkinsonian monkeys.
KW - 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
KW - Adrenal steroids
KW - Arcuate nucleus
KW - Catecholamines
KW - Melatonin
KW - Parkinson
KW - Periventricular hypothalamic area
KW - Primates
KW - Prolactin
KW - Rhythms
KW - Substantia nigra
UR - http://www.scopus.com/inward/record.url?scp=0141839815&partnerID=8YFLogxK
U2 - 10.1159/000071967
DO - 10.1159/000071967
M3 - Article
C2 - 12915764
AN - SCOPUS:0141839815
SN - 0028-3835
VL - 78
SP - 118
EP - 128
JO - Neuroendocrinology
JF - Neuroendocrinology
IS - 2
ER -